|
|
EN

  • 业务咨询

    中国：

    Email: marketing@gdrzzg.com

    业务咨询专线：400-780-8018

    （仅限服务咨询，其他事宜请拨打川沙总部电话）

    川沙总部电话: +86 (21) 5859-1500

    海外：

    +1(626)986-9880(U.S. - West Coast)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

在线留言×
点击切换
Customer Center
客户中心

WYC-209可抑制恶性小鼠黑色素瘤肿瘤再生细胞增殖，SPR分析通过合乐HL8使用Biacore 8K设备进行

2023-06-28
|
访问量：

17-WYC-209-1.jpg

Developing novel drugs that can abrogate the growth and metastasis of malignant tumors is a major challenge for cancer researchers. WYC-209, a synthetic retinoid, inhibits proliferation of malignant murine melanoma tumor-repopulating cells (TRCs). The enantiomers WYC-209A and WYC-209B exhibit similar TRC inhibition activities. The binding assay by surface plasmon resonance (SPR) analysis shows that WYC-209A and WYC-209B acid bind to RARs at nano-molar doses. SPR was carried out by Medicilon, using the Biacore 8K equipment.

Reference

Junwei Chen, et al. Inhibition of cancer stem cell like cells by a synthetic retinoid. Nat Commun. 2018 Apr 11;9(1):1406. doi: 10.1038/s41467-018-03877-7.

相关新闻